Latest News

ACP Updates Clinical Guidelines for Major Depressive Disorder Treatment

By

Diana Ernst, RPh

Publish Date January 31, 2023

The updated recommendations include both nonpharmacologic and pharmacologic interventions for adults in the acute phase of MDD.

Rural Residence Tied to Higher Risk for Heart Failure for Women, Black Men

Publish Date January 30, 2023

Findings persist after adjusting for cardiovascular risk factors and socioeconomic status.

Early Return to School After Concussion Linked to Lower Symptom Burden

By

Jeanelle Jacobs

Publish Date January 30, 2023

Study findings indicate that returning to school earlier may lead to a faster recovery after a concussion.

Are Boiled Peanuts the Answer to Peanut Allergy?

By

Kristin Della Volpe

Publish Date January 27, 2023

Researchers used sequential doses of boiled peanuts followed by roasted peanuts to desensitize children to peanut allergy.

Emergency Department Screening Detects Prediabetes, Type 2 Diabetes

Publish Date January 26, 2023

Only 25% of patients who were identified self-reported having been diagnosed with prediabetes or type 2 diabetes.

Top January 2023 FDA Approvals

By

Jeanelle Jacobs

Publish Date January 26, 2023

January FDA approvals include treatments for mood disorders, pertussis in infants, Alzheimer disease, and type 2 diabetes.

Odactra Approved for Adolescents With House Dust Mite Allergic Rhinitis

By

Diana Ernst, RPh

Publish Date January 26, 2023

Odactra is an allergen extract indicated as immunotherapy for the treatment of HDM-induced allergic rhinitis.

FDA Greenlights Ibuprofen Oral Suspension Compounding to Help With Hospital Supply

By

Diana Ernst, RPh

Publish Date January 25, 2023

Increased demand for ibuprofen oral suspension products due to a surge in 3 circulating viruses prompted the Agency to issue compounding guidance.

Uptake Low for COVID-19 Vaccine Boosters in Immunocompromised Adults

Publish Date January 25, 2023

Authors found low adherence to CDC recommendations for boosters, with older adults more likely to receive at least four mRNA COVID-19 vaccine doses.

Emzahh Gets FDA Approval for Pregnancy Prevention

By

Diana Ernst, RPh

Publish Date January 25, 2023

Emzahh is an AB-rated generic equivalent of Ortho Micronor.